The past year has been difficult for pharmaceutical giant Bristol-Myers
Dividend
A Look at Earnings Results: Lilly's Q1 results were mixed with the company surpassing earnings expectations but missing on the top line (Read more: Lilly Tops Q1 Earnings, Misses Sales, Shares Down). The company's …
Q1
The firm owned 20,361 shares of the biopharmaceutical company’s stock
Sells
Big pharma stocks have been popular among investors seeking solid …
dividend
Bristol-Myers Squibb Co. BMY, -0.32% shares surged 3.2% in premarket trade Thursday after the company reported first-quarter profit and revenue beats. Earnings for the latest quarter rose to $1.57 billion, or 94 cents …
Bristol-Myers Squibb
10 stocks we like better than Bristol-Myers Squibb When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. …
Due to its good results, and positive growth outlook and significant …
BMY
Breaking Down: Bristol-Myers Squibb Company (NYSE:BMY) has hit extreme technical weakness - watch the stochastics and technical oscillators for any kind of momentum signals if you are looking for a turnaround. …
Bristol-Myers Squibb
Bristol-Myers Squibb's (BMY) immuno-oncology drug, Opdivo — billed …
Bristol